In COPD, Nocturnal Noninvasive Ventilation Reduces the FIO2 Delivered Compared With Long-Term Oxygen Therapy at the Same Flow.
COPD
FiO2
NIV
hypercapnic
leak
oxygen therapy
Journal
Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
23
7
2020
medline:
23
2
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
Nocturnal noninvasive ventilation is recommended for patients with hypercapnic COPD. Long-term oxygen therapy improves survival in patients with hypoxemic disease. However, leaks during noninvasive ventilation are likely to reduce the fraction of inspired oxygen. To compare nocturnal inspired O This single-center prospective observational study included 14 subjects with COPD who received long-term O The mean ± SD daytime pharyngeal inspired O The nighttime inspired O
Sections du résumé
BACKGROUND
BACKGROUND
Nocturnal noninvasive ventilation is recommended for patients with hypercapnic COPD. Long-term oxygen therapy improves survival in patients with hypoxemic disease. However, leaks during noninvasive ventilation are likely to reduce the fraction of inspired oxygen.
OBJECTIVES
OBJECTIVE
To compare nocturnal inspired O
METHODS
METHODS
This single-center prospective observational study included 14 subjects with COPD who received long-term O
RESULTS
RESULTS
The mean ± SD daytime pharyngeal inspired O
CONCLUSIONS
CONCLUSIONS
The nighttime inspired O
Identifiants
pubmed: 32694183
pii: respcare.07570
doi: 10.4187/respcare.07570
doi:
Substances chimiques
Oxygen
S88TT14065
Banques de données
ClinicalTrials.gov
['NCT02599246']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1897-1903Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 by Daedalus Enterprises.